Cover Image
Market Research Report

Global Market Study on Actinic Keratosis Treatment: Demand to Surge as Preventive Care Gains Importance

Published by Persistence Market Research Product code 819782
Published Content info 275 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Market Study on Actinic Keratosis Treatment: Demand to Surge as Preventive Care Gains Importance
Published: March 8, 2019 Content info: 275 Pages
Description

Actinic Keratosis Treatment Market - Executive Summary

The actinic keratosis treatment market commences with an executive summary which provides brief yet affluent information about the actinic keratosis treatment market. A brief overview of the actinic keratosis treatment market has been provided under the heading along with exclusive recommendations and analysis from PMR analysts. All the key developments, facts, and figures have been summarized under the heading in the report.

Actinic Keratosis Treatment Market - Introduction, Background, Analysis, and Forecast

The report provides a concrete definition of the actinic keratosis market along with a detailed taxonomy of the market to help readers develop a comprehensive understanding of the actinic keratosis treatment market. Additionally, the report on actinic keratosis treatment market provides a detailed assessment of the healthcare industry and how it influences the growth of the actinic keratosis treatment market. Additionally, the report sheds light on all the macro and microeconomic facets such as drivers, restraints, threats, and challenges influencing the performance of the actinic keratosis treatment market. The report on actinic keratosis treatment market provides a detailed assessment of the drivers by further dividing them into supply side and demand side. A detailed opportunity assessment of the actinic keratosis market has also been included in the report.

The report on actinic keratosis treatment market analyzes the parent market, the prevalence of diseases, standard treatment procedures, volume of products involved in standard treatment, key regulations influencing the sales, production, and distribution of actinic keratosis treatment medications and products, and the cost incurred for treatment of the condition in different regions around the world.

A historical analysis of the actinic keratosis market along with an authentic and accurate forecast of the market has been presented in the report. The report provides a detailed breakdown of the actinic keratosis treatment market on the basis of treatment type, disease type, end users, and regions.

On the basis of treatment type, the actinic keratosis market is segmented into topical treatment, procedural modality, photodynamic therapy, and others. Based on the disease type, the actinic keratosis market has been segmented into clinical actinic keratosis and subclinical actinic keratosis. On the basis of end-users, the actinic keratosis market is segmented into, cancer treatment centers, laser therapy centers, hospitals, homecare, spas and rejuvenation centers, and private dermatology clinics. A market attractiveness analysis for each of the segments identified in the report has been provided. Additionally, th e report provides a comprehensive analysis of the actinic keratosis market on the basis of regions which includes a historical analysis as well as a forecast for each of the aforementioned segments. The report also highlights the market trends prevalent in the actinic keratosis market specifically for different regions.

Actinic Keratosis Treatment Market - Competitive Landscape

The report provides a comprehensive analysis of the competitive landscape prevalent in the actinic keratosis treatment market. A detailed assessment of the distribution of market share among the players operating in the actinic keratosis treatment market has been provided in the report. All the leading players operating in the actinic keratosis treatment market have been identified in the report. A detailed profile of each of the leading players operating in the actinic keratosis treatment market sheds light on the company's product portfolio, strengths, weaknesses, strategies, market presence, notable business developments, and global footprint. Stakeholders and business professionals operating in the actinic keratosis market can leverage the information to streamline their strategies in accordance with the ongoing trends in the market and gain maximum profitability.

Actinic Keratosis Treatment Market - Research Methodology

The report on actinic keratosis treatment market is a consequence of the elaborate and exhaustive research methodology employed during the compilation of the report. A two-step research process involving primary and secondary researches was used for obtaining actionable insights into the actinic keratosis market. Primary research involved interviewing seasoned experts from the actinic keratosis treatment market while secondary research was conducted by thoroughly studying company press releases, trade journals, paid sources, and other industry-related publications.

Results from both the steps of research were cross-referenced to filter out erroneous information and create an accurate and authentic forecast of the actinic keratosis treatment market.

Table of Contents

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. FMI Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition
  • 2.3. Exclusion and Inclusion

3. Global Economic Outlook

  • 3.1. Gross Domestic Product by Region & Country, 2006 - 2021
  • 3.2. Global Healthcare Market Indicators

4. Market Opportunity Analysis

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis

5. Market Dynamics

  • 5.1. Drivers
    • 5.1.1. Supply Side Drivers
    • 5.1.2. Demand Side Drivers
  • 5.2. Restraints
  • 5.3. Trends

6. Market Data Call Out

  • 6.1. Parent Market Analysis
  • 6.2. Disease Epidemiology
  • 6.3. Treatment Regimen
  • 6.4. Procedure Volume of Cosmetic Therapies
  • 6.5. Key Regulations
  • 6.6. Reimbursement Scenario and Payer Mix Analysis
  • 6.7. Treatment Cost by Region

7. North America Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 7.4.1. Topical Treatment
      • 7.4.1.1. 5-fluorouracil Cream
      • 7.4.1.2. Diclofenac Gel
      • 7.4.1.3. Imiquimod Cream
      • 7.4.1.4. Ingenol mebutate Gel
    • 7.4.2. Procedural Modality
      • 7.4.2.1. Chemical Peels
      • 7.4.2.2. Cryotherapy
    • 7.4.3. Photodynamic Therapy
    • 7.4.4. Others
  • 7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 7.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 7.6.1. Clinical AK
    • 7.6.2. Subclinical AK
  • 7.7. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 7.8.1. Hospitals
    • 7.8.2. Private Dermatology Clinics
    • 7.8.3. Laser Therapy Centers
    • 7.8.4. Cancer Treatment Centers
    • 7.8.5. Spas and Rejuvenation Centers
    • 7.8.6. Homecare
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Treatment Type
    • 7.10.3. By Disease Type
    • 7.10.4. By End User
  • 7.11. Drivers and Restraints: Impact Analysis
  • 7.12. Key Market Participants - Intensity Mapping

8. Latin America Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 8.1. Introduction
  • 8.2. Regional Market Trends
  • 8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 8.3.1. Brazil
    • 8.3.2. Mexico
    • 8.3.3. Rest of Latin America
  • 8.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 8.5.1. Topical Treatment
      • 8.5.1.1. 5-fluorouracil Cream
      • 8.5.1.2. Diclofenac Gel
      • 8.5.1.3. Imiquimod Cream
      • 8.5.1.4. Ingenol mebutate Gel
    • 8.5.2. Procedural Modality
      • 8.5.2.1. Chemical Peels
      • 8.5.2.2. Cryotherapy
    • 8.5.3. Photodynamic Therapy
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 8.7. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 8.7.1. Clinical AK
    • 8.7.2. Subclinical AK
  • 8.8. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 8.9.1. Hospitals
    • 8.9.2. Private Dermatology Clinics
    • 8.9.3. Laser Therapy Centers
    • 8.9.4. Cancer Treatment Centers
    • 8.9.5. Spas and Rejuvenation Centers
    • 8.9.6. Homecare
  • 8.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Treatment Type
    • 8.11.3. By Disease Type
    • 8.11.4. By End User
  • 8.12. Drivers and Restraints: Impact Analysis
  • 8.13. Key Market Participants - Intensity Mapping

9. Western Europe Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 9.2.1. Germany
    • 9.2.2. U.K
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Western Europe
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 9.4.1. Topical Treatment
      • 9.4.1.1. 5-fluorouracil Cream
      • 9.4.1.2. Diclofenac Gel
      • 9.4.1.3. Imiquimod Cream
      • 9.4.1.4. Ingenol mebutate Gel
    • 9.4.2. Procedural Modality
      • 9.4.2.1. Chemical Peels
      • 9.4.2.2. Cryotherapy
    • 9.4.3. Photodynamic Therapy
    • 9.4.4. Others
  • 9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 9.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 9.6.1. Clinical AK
    • 9.6.2. Subclinical AK
  • 9.7. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 9.8.1. Hospitals
    • 9.8.2. Private Dermatology Clinics
    • 9.8.3. Laser Therapy Centers
    • 9.8.4. Cancer Treatment Centers
    • 9.8.5. Spas and Rejuvenation Centers
    • 9.8.6. Homecare
  • 9.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 9.10. Market Attractiveness Analysis
    • 9.10.1. By Country
    • 9.10.2. By Treatment Type
    • 9.10.3. By Disease Type
    • 9.10.4. By End User
  • 9.11. Drivers and Restraints: Impact Analysis
  • 9.12. Key Market Participants - Intensity Mapping

10. Eastern Europe Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 10.2.1. Russia
    • 10.2.2. Poland
    • 10.2.3. Rest of Eastern Europe
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (1/2)
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (2/2)
  • Table 03: Prescription Pattern for Actinic Keratosis Treatment
  • Table 04: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (1/2)
  • Table 05: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (2/2)
  • Table 06: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (1/2)
  • Table 07: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (2/2)
  • Table 08: CPT code for Actinic Keratosis Treatment (1/4)
  • Table 09: CPT code for Actinic Keratosis Treatment (2/4)
  • Table 10: CPT code for Actinic Keratosis Treatment (3/4)
  • Table 11: CPT code for Actinic Keratosis Treatment (4/4)
  • Table 12: HCPCS code for Actinic Keratosis Treatment
  • Table 13: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 14: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 15: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 16: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 17: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 18: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 19: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 20: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 21: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 22: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 23: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 24: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 25: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 26: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 27: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 28: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 29: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 30: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 31: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 32: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 33: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 34: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 35: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 36: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 37: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 38: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 39: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 40: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Region
  • Table 41: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Treatment Type
  • Table 42: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Disease Type
  • Table 43: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By End User 4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 10.4.1. Topical Treatment
      • 10.4.1.1. 5-fluorouracil Cream
      • 10.4.1.2. Diclofenac Gel
      • 10.4.1.3. Imiquimod Cream
      • 10.4.1.4. Ingenol mebutate Gel
    • 10.4.2. Procedural Modality
      • 10.4.2.1. Chemical Peels
      • 10.4.2.2. Cryotherapy
    • 10.4.3. Photodynamic Therapy
    • 10.4.4. Others
  • 10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 10.6.1. Clinical AK
    • 10.6.2. Subclinical AK
  • 10.7. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 10.8.1. Hospitals
    • 10.8.2. Private Dermatology Clinics
    • 10.8.3. Laser Therapy Centers
    • 10.8.4. Cancer Treatment Centers
    • 10.8.5. Spas and Rejuvenation Centers
    • 10.8.6. Homecare
  • 10.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 10.10.Market Attractiveness Analysis
    • 10.10.1. By Country
    • 10.10.2. By Treatment Type
    • 10.10.3. By Disease Type
    • 10.10.4. By End User
  • 10.11.Drivers and Restraints: Impact Analysis
  • 10.12.Key Market Participants - Intensity Mapping

11. Asia Pacific Excluding Japan Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 11.2.1. India
    • 11.2.2. Australia and New Zealand
    • 11.2.3. China
    • 11.2.4. ASEAN
    • 11.2.5. Rest of APECJ
  • 11.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 11.4.1. Topical Treatment
      • 11.4.1.1. 5-fluorouracil Cream
      • 11.4.1.2. Diclofenac Gel
      • 11.4.1.3. Imiquimod Cream
      • 11.4.1.4. Ingenol mebutate Gel
    • 11.4.2. Procedural Modality
      • 11.4.2.1. Chemical Peels
      • 11.4.2.2. Cryotherapy
    • 11.4.3. Photodynamic Therapy
    • 11.4.4. Others
  • 11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 11.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 11.6.1. Clinical AK
    • 11.6.2. Subclinical AK
  • 11.7. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 11.8.1. Hospitals
    • 11.8.2. Private Dermatology Clinics
    • 11.8.3. Laser Therapy Centers
    • 11.8.4. Cancer Treatment Centers
    • 11.8.5. Spas and Rejuvenation Centers
    • 11.8.6. Homecare
  • 11.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 11.10.Market Attractiveness Analysis
    • 11.10.1. By Country
    • 11.10.2. By Treatment Type
    • 11.10.3. By Disease Type
    • 11.10.4. By End User
  • 11.11. Drivers and Restraints: Impact Analysis
  • 11.12. Key Market Participants - Intensity Mapping

12. Japan Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 12.2.1. Topical Treatment
      • 12.2.1.1. 5-fluorouracil Cream
      • 12.2.1.2. Diclofenac Gel
      • 12.2.1.3. Imiquimod Cream
      • 12.2.1.4. Ingenol mebutate Gel
    • 12.2.2. Procedural Modality
      • 12.2.2.1. Chemical Peels
      • 12.2.2.2. Cryotherapy
    • 12.2.3. Photodynamic Therapy
    • 12.2.4. Others
  • 12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 12.4. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 12.4.1. Clinical AK
    • 12.4.2. Subclinical AK
  • 12.5. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 12.6.1. Hospitals
    • 12.6.2. Private Dermatology Clinics
    • 12.6.3. Laser Therapy Centers
    • 12.6.4. Cancer Treatment Centers
    • 12.6.5. Spas and Rejuvenation Centers
    • 12.6.6. Homecare
  • 12.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Country
    • 12.8.2. By Treatment Type
    • 12.8.3. By Disease Type
    • 12.8.4. By End User
  • 12.9. Drivers and Restraints: Impact Analysis
  • 12.10. Key Market Participants - Intensity Mapping

13. Middle East and Africa Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of Middle East and Africa
  • 13.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 13.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
    • 13.4.1. Topical Treatment
      • 13.4.1.1. 5-fluorouracil Cream
      • 13.4.1.2. Diclofenac Gel
      • 13.4.1.3. Imiquimod Cream
      • 13.4.1.4. Ingenol mebutate Gel
    • 13.4.2. Procedural Modality
      • 13.4.2.1. Chemical Peels
      • 13.4.2.2. Cryotherapy
    • 13.4.3. Photodynamic Therapy
    • 13.4.4. Others
  • 13.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 13.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013-2017
    • 13.6.1. Clinical AK
    • 13.6.2. Subclinical AK
  • 13.7. Market Size (US$ Mn) Forecast By Disease Type, 2018-2028
  • 13.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
    • 13.8.1. Hospitals
    • 13.8.2. Private Dermatology Clinics
    • 13.8.3. Laser Therapy Centers
    • 13.8.4. Cancer Treatment Centers
    • 13.8.5. Spas and Rejuvenation Centers
    • 13.8.6. Homecare
  • 13.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 13.10.Market Attractiveness Analysis
    • 13.10.1. By Country
    • 13.10.2. By Treatment Type
    • 13.10.3. By Disease Type
    • 13.10.4. By End User
  • 13.11. Drivers and Restraints: Impact Analysis
  • 13.12. Key Market Participants - Intensity Mapping

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

  • 16.1. Market Structure by Tier
  • 16.2. Brand Share Analysis (2017) for Photodynamic Theraphy
  • 16.3. Product Intensity Mapping by Manufacturer

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competitors Deep Dive
    • 17.2.1. Sun Pharmaceutical Industries Ltd.
    • 17.2.2. Biofrontera
    • 17.2.3. Nestle SA
    • 17.2.4. Bausch Health Companies Inc.
    • 17.2.5. Novartis AG
    • 17.2.6. GlaxoSmithKline plc.
    • 17.2.7. Almirall, LLC
    • 17.2.8. LEO Pharma Inc.
    • 17.2.9. Cipher Pharmaceuticals Inc
    • 17.2.10.Pierre Fabre Pharmaceuticals, Inc.
    • 17.2.11.BioLineRX
    • 17.2.12.Alma Lasers
    • 17.2.13.Valeant Pharmaceuticals
      • 17.2.14.3M
    • 17.2.15.Stanford Chemicals.

18. Global Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028 By Region

  • 18.1. Introduction / Key Findings
  • 18.2. Historical Market Size (US$ Mn) Analysis By Region
    • 18.2.1. North America
    • 18.2.2. Latin America
    • 18.2.3. Western Europe
    • 18.2.4. Eastern Europe
    • 18.2.5. Asia Pacific Excluding Japan
    • 18.2.6. Japan
    • 18.2.7. Middle East and Africa
  • 18.3. Market Size (US$ Mn) Forecast By Region
  • 18.4. Market Attractiveness Analysis By Region

19. Global Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type

  • 19.1. Introduction/Key Finding
  • 19.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013-2017
    • 19.2.1. Topical Treatment
      • 19.2.1.1. 5-fluorouracil Cream
      • 19.2.1.2. Diclofenac Gel
      • 19.2.1.3. Imiquimod Cream
      • 19.2.1.4. Ingenol mebutate Gel
    • 19.2.2. Procedural Modality
      • 19.2.2.1. Chemical Peels
      • 19.2.2.2. Cryotherapy
    • 19.2.3. Photodynamic Therapy
    • 19.2.4. Others
  • 19.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
  • 19.4. Market Attractiveness Analysis By Treatment Type

20. Global Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028, By End User

  • 20.1. Introduction/Key Finding
  • 20.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2017
    • 20.2.1. Clinical AK
    • 20.2.2. Subclinical AK
  • 20.3. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 20.4. Market Attractiveness Analysis By End User

21. Global Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028, By End User

  • 21.1. Introduction/Key Finding
  • 21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2017
    • 21.2.1. Hospitals
    • 21.2.2. Private Dermatology Clinics
    • 21.2.3. Laser Therapy Centers
    • 21.2.4. Cancer Treatment Centers
    • 21.2.5. Spas and Rejuvenation Centers
    • 21.2.6. Homecare
  • 21.3. Market Size (US$ Mn) Forecast By End User, 2018-2028
  • 21.4. Market Attractiveness Analysis By End User

22. Global Actinic Keratosis Treatment Market Analysis 2013-2017 and Forecast 2018-2028

  • 22.1. Market Value Analysis (US$ Mn)
  • 22.2. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (1/2)
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (2/2)
  • Table 03: Prescription Pattern for Actinic Keratosis Treatment
  • Table 04: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (1/2)
  • Table 05: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (2/2)
  • Table 06: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (1/2)
  • Table 07: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (2/2)
  • Table 08: CPT code for Actinic Keratosis Treatment (1/4)
  • Table 09: CPT code for Actinic Keratosis Treatment (2/4)
  • Table 10: CPT code for Actinic Keratosis Treatment (3/4)
  • Table 11: CPT code for Actinic Keratosis Treatment (4/4)
  • Table 12: HCPCS code for Actinic Keratosis Treatment
  • Table 13: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 14: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 15: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 16: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 17: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 18: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 19: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 20: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 21: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 22: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 23: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 24: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 25: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 26: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 27: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 28: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 29: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 30: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 31: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 32: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 33: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 34: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 35: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 36: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 37: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Table 38: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Disease Type
  • Table 39: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 40: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Region
  • Table 41: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Treatment Type
  • Table 42: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By Disease Type
  • Table 43: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013-2028, By End User
  • Figure 01: Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 02: Prevalence Of Actinic Keratosis Among Male in Different Degree of Latitude
  • Figure 03: Prevalence Of Actinic Keratosis Among Female in Different Degree of Latitude
  • Figure 04: Global Dermatology Market Overview
  • Figure 05: Payer Mix Analysis - U.S.
  • Figure 06: Photo Dynamic Therapy Per Session Cost (US$), By Region (2017)
  • Figure 07: Chemical Peel Procedure Per Session Cost (US$), By Region (2017)
  • Figure 08: Cryotherapy Procedure Cost (US$), By Region (2017)
  • Figure 09: Topical Treatment Cost (US$), By Region (2017)
  • Figure 10: North America Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 11 : North America Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 12: North America Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 13: North America Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 14: North America Actinic Keratosis Treatment Market Value Analysis
  • Figure 15: North America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 16: U.S. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 17: U.S. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 18: Canada Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 19: Canada Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 20: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 21: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 22: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 23: North America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 24: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 25 : Latin America Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 26: Latin America Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 27: Latin America Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 28: Latin America Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 29: Latin America Actinic Keratosis Treatment Market Value Analysis
  • Figure 30: Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 31: Brazil Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 32: Brazil Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 33: Mexico Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 34: Mexico Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 35: Rest of Latin America Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 36: Rest of Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 37: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 38: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 39: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 40: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 41: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 42: Western Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 43: Western Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 44: Western Europe Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 45: Western Europe Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 46: Western Europe Actinic Keratosis Treatment Market Value Analysis
  • Figure 47: Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 48: U.K. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 49: U.K. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 50: Germany Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 51: Germany Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 52: France Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 53: France Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 54: Italy Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 55: Italy Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 56: Spain Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 57: Spain Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 58: Rest of Western Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 59: Rest of Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 60: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 61: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 62: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 63: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 64: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 65: Eastern Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 66: Eastern Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 67: Eastern Europe Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 68: Eastern Europe Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 69: Eastern Europe Actinic Keratosis Treatment Market Value Analysis
  • Figure 70: Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 71: Russia Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 72: Russia Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 73: Poland Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 74: Poland Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 75: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 76: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 77: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 78: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 79: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 80: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 81: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 82: APEJ Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 83: APEJ Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 84: APEJ Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 85: APEJ Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 86: APEJ Actinic Keratosis Treatment Market Value Analysis
  • Figure 87: APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 88: India Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 89: India Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 90: Australia & NZ Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 91: Australia & NZ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 92: China Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 93: China Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 94: ASEAN Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 95: ASEAN Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 96: Rest of APEJ Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 97: Rest of APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 98: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 99: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 100: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 101: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 102: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 103: Japan Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 104: Japan Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 105: Japan Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 106: Japan Actinic Keratosis Treatment Market Value Analysis
  • Figure 107: Japan Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 108: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 109: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 110: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 111: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 112: MEA Actinic Keratosis Treatment Market Value Share By Treatment Type (2018 E)
  • Figure 113: MEA Actinic Keratosis Treatment Market Value Share By Disease Type (2018 E)
  • Figure 114: MEA Actinic Keratosis Treatment Market Value Share By End User (2018 E)
  • Figure 115: MEA Actinic Keratosis Treatment Market Value Share By Country (2018 E)
  • Figure 116: MEA Actinic Keratosis Treatment Market Value Analysis
  • Figure 117: MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 118: South Africa Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 119: South Africa Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 120: GCC Countries Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
  • Figure 121: GCC Countries Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 122: Rest of MEA Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 123: Rest of MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2018-2028
  • Figure 124: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment Type
  • Figure 125: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 126: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 127: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 128: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2018-2028
  • Figure 129: Global Photodynamic Therapy Market: Brand Share Analysis Share Analysis (2017)
  • Figure 130: Global Actinic Keratosis Treatment Market Share Analysis (%), By Region, 2018 & 2028
  • Figure 131: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Region, 2018-2028
  • Figure 132: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2018-2028
  • Figure 133: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2018-2028
  • Figure 134: Global Actinic Keratosis Treatment Market Share Analysis (%), By Treatment Type, 2018 & 2028
  • Figure 135: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Treatment Type, 2018-2028
  • Figure 136: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2018-2028
  • Figure 137: Global Actinic Keratosis Treatment Market Share Analysis (%), By Disease Type, 2018 & 2028
  • Figure 138: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Disease Type, 2018-2028
  • Figure 139: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2018-2028
  • Figure 140: Global Actinic Keratosis Treatment Market Share Analysis (%), By End User, 2018 & 2028
  • Figure 141: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By End User, 2018-2028
  • Figure 142: Global Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2018-2028
  • Figure 143: Global Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013-2017
  • Figure 144: Global Actinic Keratosis Treatment Market Value Forecast (US$ Mn),
  • Figure 145: Global Actinic Keratosis Treatment Market Absolute $ Opportunity, 2018 - 2028
  • Back to Top